Healthcare News

Browse the latest Healthcare news, including Healthcare Providers, Medical Equipment, Medical Supplies and Services, Biotechnology and Pharmaceuticals, and Cannabis industries. Use the menu or navigation tiles to get to specific industries within each sector.

January 21, 2026 12:02 ET | Source: AB Science

AB Science obtient un brevet japonais pour l'utilisation du masitinib dans le traitement des formes progressives de la sclérose en plaques (SEP) jusqu'en 2041

COMMUNIQUÉ DE PRESSE AB SCIENCE OBTIENT UN BREVET JAPONAIS POUR L'UTILISATION DU MASITINIB DANS LE TRAITEMENT DES FORMES PROGRESSIVES DE LA SCLÉROSE EN PLAQUES (SEP) JUSQU'EN 2041 IL S'AGIT DU...
January 21, 2026 12:02 ET | Source: AB Science

AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041

PRESS RELEASE AB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL 2041 THIS IS THE FIRST COUNTRY DELIVERING THE MS PATENT ...
January 21, 2026 12:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search

TARRYTOWN N.Y. and WASHINGTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Society for Science (the Society) and Regeneron today announced the top 40 finalists in the Regeneron Science Talent Search 2026,...
January 21, 2026 12:00 ET | Source: IBA SA

IBA SA – NOTIFICATION TRANSPARENCE

(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 21 janvier 2026, 18:00 Résumé de la notification IBA (Ion...
January 21, 2026 12:00 ET | Source: IBA SA

IBA – TRANSPARENCY NOTIFICATION

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 21, 2026 06:00 PM Summary of the notification IBA (Ion Beam...
January 21, 2026 12:00 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics salue l'octroi de la désignation de médicament orphelin par la FDA du pegrizprument (VEL-101)

OSE Immunotherapeutics salue l'octroi de la désignation de médicament orphelin par la FDA du pegrizprument (VEL-101) Nantes, le 21 janvier, 18 heures - OSE Immunotherapeutics SA (ISIN: FR0012127173;...
January 21, 2026 12:00 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)
January 21, 2026 11:45 ET | Source: Ipsen Pharma

Le tribunal arbitral confirme la résiliation par Ipsen de l'accord de R&D conclu avec Galderma

PARIS, FRANCE, 21 janvier 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce que le Tribunal arbitral de la Chambre de commerce internationale (CCI) a rendu une décision finale en faveur d'Ipsen,...
January 21, 2026 11:45 ET | Source: Ipsen Pharma

Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma

PARIS, FRANCE, 21 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced that the Arbitral Tribunal of the International Chamber of Commerce (ICC) has issued a final decision in favor of Ipsen,...
January 21, 2026 11:21 ET | Source: HNL Lab Medicine

HNL Lab Medicine Expands Services with New Pocono Creek Patient Service Center Featuring Dedicated Pediatric Phlebotomy Space

BARTONSVILLE, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine, a trusted leader in comprehensive laboratory testing services, is pleased to announce the opening of its newest Patient...